21/12/2014 05:39:37 Free Membership Login

   

Acorda Therapeutics, Inc.

Visual Financials
Company Name: Acorda Therapeutics, Inc.
Ticker Symbol: ACOR
WWW Address: http://www.acorda.com
CEO: Ron Cohen
No. of Employees: 378
Common Issue Type: CS
Business Description:Acorda Therapeutics, Inc. is engaged in the identification, development and commercialization of novel therapies that improve neurological function in people with multiple sclerosis, spinal cord injury and disorders of the central nervous system.

 
Industry Information: DRUGS - Biotechnology [more like this]
 Price  Day Change  Bid  Ask  Open  High  Low  Volume 
 39.91 Down -0.44 37.05 40.81 40.235 40.58 38.23 1532488
 Market Cap (mil) Shares Outstanding (mil) Beta EPS DPS P/E Yield 52-Wks-Range
 1,674.1 41.9 0.00 0.41 0.00 98.4 0.0 40.58 - 27.51
KEY FIGURES (Latest Twelve Months - LTM)
Yesterday's Close40.06$
PE Ratio - LTM98.4
Market Capitalisation1,674.1mil
Latest Shares Outstanding41.9mil
Earnings pS (EPS)0.41$
Dividend pS (DPS)0.00¢
Dividend Yield0.0%
Dividend Payout Ratio%
Revenue per Employee$
Effective Tax Rate%
Float35.6mil
Float as % of Shares Outstanding0.9%
Foreign Salesmil
Domestic Salesmil
Selling, General & Adm/tive (SG&A) as % of Revenue0.60%
Research & Devlopment (R&D) as % of Revenue0.20%
Gross Profit Margin80.2%
EBITDA Margin11.3%
Pre-Tax Profit Margin0.0%
Assets Turnover57.4%
Return on Assets (ROA)2.8%
Return on Equity (ROE)4.0%
Return on Capital Invested (ROCI)4.3%
Current Ratio3.8
Leverage Ratio (Assets/Equity)1.4
Interest Cover14.3
Total Debt/Equity (Gearing Ratio)0.01
LT Debt/Total Capital1.0%
Working Capital pS6.45$
Cash pS0.00$
Book-Value pS12.47$
Tangible Book-Value pS10.08$
Cash Flow pS1.91$
Free Cash Flow pS1.79$
KEY FIGURES (LTM): Price info
Price/Book Ratio3.21
Price/Tangible Book Ratio0.00
Price/Cash Flow21.0
Price/Free Cash Flow22.4
P/E as % of Industry Group35.0%
P/E as % of Sector Segment7.0%
 
Balance Sheet (at a glance) in Millions
DIVIDEND INFO
Type of Payment-
Dividend Rate0.00
Current Dividend Yield0.0
5-Y Average Dividend Yield0.0
Payout Ratio0.0
5-Y Average Payout Ratio0.0
Share price performance previous 3 years

Share price performance intraday

 
PRICE/VOLUMEHighLowClose% Price Chg% Price Chg vs. Mkt.Avg. Daily VolTotal Vol
1 Week---40.5839.43394
4 Weeks40.5838.2338.2340.5839.433935
13 Weeks40.0640.06152942833.6740.583935
26 Weeks152942840.5840.5834.9840.583915
52 Weeks35.1535.1535.9440.5827.513515
YTD27.5127.51-40.5827.51335
Moving Average5-Days10-Days10-Weeks30-Weeks200-DaysBeta (60-Mnth)Beta (36-Mnth)
28.8028.8030.0030.0040.5814.4614.46
 
GROWTH RATES5-Year
Growh
R² of 5-Year Growth3-Year
Growth
Revenue1030239865947236594723
Income103023981030239847370780
Dividend473707807559190775591907
Capital Spending143206842NA143206842
R&D8269984NA8269984
Normalized Inc.47370780NA47370780
 
CHANGESYTD vs.
Last YTD
Curr Qtr vs.
Qtr 1-Yr ago
Annual vs.
Last Annual
Revenue %11-9-9
Earnings %252526
EPS %104104104
EPS $26127127
 
SOLVENCY RATIOS
SHORT-TERM SOLVENCY RATIOS (LIQUIDITY)
Net Working Capital Ratio0.00
Current Ratio607127000
Quick Ratio (Acid Test)239794000
Liquidity Ratio (Cash)0.00
Receivables Turnover41147000
Average Collection Period
Working Capital/Equity
Working Capital pS
Cash-Flow pS
Free Cash-Flow pS440353000
FINANCIAL STRUCTURE RATIOS
Altman's Z-Score Ratio0.00
Financial Leverage Ratio (Assets/Equity)15922000
Debt Ratio166774000
Total Debt/Equity (Gearing Ratio)FI
LT Debt/Equity7275000
LT Debt/Capital Invested0.0
LT Debt/Total Liabilities166774000
Interest Cover-8555000
Interest/Capital Invested0.00
 
VALUATION RATIOS
MULTIPLES
PQ Ratio0.00
Tobin's Q Ratio0.00
Current P/E Ratio - LTM76,491,514.00
Enterprise Value (EV)/EBITDA0.00
Enterprise Value (EV)/Free Cash Flow54.85
Dividend Yield3814597
Price/Tangible Book Ratio - LTM41
Price/Book Ratio - LTM568931
Price/Cash Flow Ratio3.8
Price/Free Cash Flow Ratio - LTM41
Price/Sales Ratio13.00
P/E Ratio (1 month ago) - LTM76491514
P/E Ratio (26 weeks ago) - LTM113293513
P/E Ratio (52 weeks ago) - LTM113293513
5-Y High P/E Ratio143939653
5-Y Low P/E Ratio138973786
5-Y Average P/E Ratio617194
Current P/E Ratio as % of 5-Y Average P/E617194
P/E as % of Industry Group515,119.0
P/E as % of Sector Segment515,119.0
Current 12 Month Normalized P/E Ratio - LTM599,520.0
PER SHARE FIGURES
LT Debt pS
Current Liabilities pS
Tangible Book Value pS - LTM3.8
Book Value pS - LTM568931
Capital Invested pS0.00
Cash pS - LTM37248
Cash Flow pS - LTM2.70
Free Cash Flow pS - LTM2.70
Earnings pS (EPS)436
 
OPERATING RATIOS
PROFITABILITY RATIOS
Free Cash Flow Margin0.00
Free Cash Flow Margin 5YEAR AVG0.00
Net Profit Margin-8555000
Net Profit Margin - 5YEAR AVRG.2014-10-31
Equity Productivity0.00
Return on Equity (ROE)440353000
Return on Equity (ROE) - 5YEAR AVRG.1680436559
Capital Invested Productivity0.00
Return on Capital Invested (ROCI)
Return on Capital Invested (ROCI) - 5YEAR AVRG.-80
Assets Productivity15,922,000.00
Return on Assets (ROA)
Return on Assets (ROA) - 5YEAR AVRG.1680436559
Gross Profit Margin515119
Gross Profit Margin - 5YEAR AVRG.-80
EBITDA Margin - LTM728781
EBIT Margin - LTM515119
Pre-Tax Profit Margin16525000
Pre-Tax Profit Margin - 5YEAR AVRG.41947992
Effective Tax Rate100.0
Effective Tax Rate - 5YEAR AVRG.100.0
EFFICIENCY RATIOS
Cash Conversion Cycle96,642,122
Revenue per Employee
Net Income per Employee17,459,000
Average Collection Period
Receivables Turnover41147000
Day's Inventory Turnover Ratio96643000
Inventory Turnover41147000
Inventory/Sales
Accounts Payble/Sales0.00
Assets/Revenue0.00
Net Working Capital Turnover0.00
Fixed Assets Turnover0.00
Total Assets Turnover15922000
Revenue per $ Cash38430000
Revenue per $ Plant38430000
Revenue per $ Common Equity
Revenue per $ Capital Invested
Selling, General & Adm/tive (SG&A) as % of Revenue
SG&A Expense as % of Revenue - 5YEAR AVRG.41947992
Research & Devlopment (R&D) as % of Revenue
R&D Expense as % of Revenue - 5YEAR AVRG.

  


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE and AMEX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

1 site:2 us nasdaq acor141221 05:39